John G. Ullman & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.16M | Sell |
|
|||||
|
2025
Q1 | $9.48M | Sell |
|
|||||
|
2024
Q4 | $8.81M | Sell |
|
|||||
|
2024
Q3 | $8.19M | Sell |
|
|||||
|
2024
Q2 | $9.46M | Sell |
|
|||||
|
2024
Q1 | $18.1M | Sell |
|
|||||
|
2023
Q4 | $18.5M | Buy |
|
|||||
|
2023
Q3 | $20.6M | Sell |
|
|||||
|
2023
Q2 | $23M | Sell |
|
|||||
|
2023
Q1 | $25.5M | Sell |
|
|||||
|
2022
Q4 | $27.1M | Sell |
|
|||||
|
2022
Q3 | $27M | Sell |
|
|||||
|
2022
Q2 | $29.6M | Sell |
|
|||||
|
2022
Q1 | $28.2M | Sell |
|
|||||
|
2021
Q4 | $24.3M | Sell |
|
|||||
|
2021
Q3 | $23.1M | Sell |
|
|||||
|
2021
Q2 | $26.1M | Sell |
|
|||||
|
2021
Q1 | $25M | Sell |
|
|||||
|
2020
Q4 | $25M | Sell |
|
|||||
|
2020
Q3 | $24.6M | Sell |
|
|||||
|
2020
Q2 | $24.1M | Sell |
|
|||||
|
2020
Q1 | $22.9M | Sell |
|
|||||
|
2019
Q4 | $26.6M | Sell |
|
|||||
|
2019
Q3 | $21.1M | Buy |
|
|||||
|
2019
Q2 | $16.2M | Buy |
|
|||||
|
2019
Q1 | $12.8M | Buy |
|
|||||
|
2018
Q4 | $12.3M | Buy |
|
|||||
|
2018
Q3 | $10.4M | Sell |
|
|||||
|
2018
Q2 | $9.35M | Buy |
|
|||||
|
2018
Q1 | $8.4M | Sell |
|
|||||
|
2017
Q4 | $8.22M | Buy |
|
|||||
|
2017
Q3 | $8.5M | Sell |
|
|||||
|
2017
Q2 | $7.46M | Sell |
|
|||||
|
2017
Q1 | $7.37M | Sell |
|
|||||
|
2016
Q4 | $8.05M | Sell |
|
|||||
|
2016
Q3 | $7.46M | Sell |
|
|||||
|
2016
Q2 | $10.5M | Sell |
|
|||||
|
2016
Q1 | $9.22M | Sell |
|
|||||
|
2015
Q4 | $10.3M | Sell |
|
|||||
|
2015
Q3 | $9.2M | Sell |
|
|||||
|
2015
Q2 | $10.6M | Sell |
|
|||||
|
2015
Q1 | $10.7M | Sell |
|
|||||
|
2014
Q4 | $13.1M | Sell |
|
|||||
|
2014
Q3 | $11.5M | Sell |
|
|||||
|
2014
Q2 | $11.1M | Sell |
|
|||||
|
2014
Q1 | $12.1M | Sell |
|
|||||
|
2013
Q4 | $13M | Sell |
|
|||||
|
2013
Q3 | $14M | Sell |
|
|||||
|
2013
Q2 | $13.8M | Buy |
|